IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

MARFELLA, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.487
EU - Europa 2.118
AS - Asia 932
SA - Sud America 263
AF - Africa 131
OC - Oceania 1
Totale 5.932
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.397
RU - Federazione Russa 1.526
SG - Singapore 362
CN - Cina 200
BR - Brasile 189
DE - Germania 131
IT - Italia 120
FR - Francia 114
VN - Vietnam 103
CI - Costa d'Avorio 96
HK - Hong Kong 72
GB - Regno Unito 55
BD - Bangladesh 53
CA - Canada 49
IN - India 29
MX - Messico 29
PL - Polonia 27
IE - Irlanda 25
AR - Argentina 22
FI - Finlandia 20
ES - Italia 19
NL - Olanda 18
ID - Indonesia 17
IQ - Iraq 17
ZA - Sudafrica 17
JP - Giappone 14
AT - Austria 13
UA - Ucraina 12
EC - Ecuador 11
CO - Colombia 10
CZ - Repubblica Ceca 10
LT - Lituania 9
CL - Cile 8
VE - Venezuela 7
PK - Pakistan 6
SE - Svezia 6
TR - Turchia 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
JO - Giordania 5
MA - Marocco 5
MY - Malesia 5
PH - Filippine 5
SA - Arabia Saudita 5
TH - Thailandia 5
UY - Uruguay 5
PE - Perù 4
RO - Romania 4
UZ - Uzbekistan 4
DZ - Algeria 3
HN - Honduras 3
PT - Portogallo 3
TW - Taiwan 3
BE - Belgio 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IL - Israele 2
JM - Giamaica 2
NP - Nepal 2
PY - Paraguay 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.932
Salva come PNG Salva come JPEG
Città #
Dallas 1.010
Moscow 520
San Jose 423
Ashburn 201
Singapore 189
Abidjan 96
Frankfurt am Main 91
Beijing 83
Hong Kong 71
The Dalles 70
Lauterbourg 55
New York 51
Los Angeles 49
Ho Chi Minh City 44
Boardman 27
Dublin 25
Santa Clara 25
Orem 24
Warsaw 24
Denver 20
Hanoi 20
São Paulo 20
Chennai 18
Brooklyn 16
Montreal 16
Munich 16
London 15
Amsterdam 13
Poplar 13
Tokyo 13
Toronto 13
Chicago 11
Campobasso 10
Council Bluffs 10
Helsinki 10
Houston 10
Jacksonville 10
Manchester 10
Mexico City 10
Nuremberg 10
San Francisco 10
Atlanta 9
Boston 9
Phoenix 9
Brno 8
Columbus 8
Johannesburg 8
Naples 8
Querétaro 8
Terzigno 8
Chandler 7
Falkenstein 7
Hillsboro 7
Mumbai 7
Roubaix 7
Baghdad 6
Curitiba 6
Córdoba 6
Rio de Janeiro 6
Acerra 5
Ankara 5
Bexley 5
Buffalo 5
Lappeenranta 5
Memphis 5
Milan 5
Montevideo 5
Rome 5
Santiago 5
Stockholm 5
Turku 5
Vienna 5
Amman 4
Assago 4
Bangkok 4
Charlotte 4
Da Nang 4
Erbil 4
Guarulhos 4
Haiphong 4
Jakarta 4
Kingston 4
Limburg an der Lahn 4
Ottawa 4
Tashkent 4
Vancouver 4
Wilmington 4
Baie-D'Urfé 3
Brasília 3
Caracas 3
Casablanca 3
Guayaquil 3
Lahore 3
Lima 3
Medellín 3
Mosul 3
Pasadena 3
Porto Alegre 3
Providence 3
Quito 3
Totale 3.670
Salva come PNG Salva come JPEG
Nome #
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 618
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 146
ELectrophysiological mechanisms underlying the Inhibitory CArdiac syncope without asystolic significant pause: Therapeutic and prognostic implications. The ELICA randomized trial 139
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 138
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 135
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 128
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 128
Advances in Nanomedicine for Precision Insulin Delivery 126
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 121
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 120
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 118
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 116
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 116
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 114
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 113
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 112
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 110
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 110
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 107
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 103
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 100
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 100
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 98
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 98
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 97
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 93
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 88
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 87
Cardiovascular benefits from gliflozins: Effects on endothelial function 85
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 85
Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity 81
Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients 80
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 79
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 74
MicroRNAs modulation and clinical outcomes at 1 year of follow-up in obese patients with pre-diabetes treated with metformin vs. placebo 73
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 72
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 71
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 70
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 70
Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19 69
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 65
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 65
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 64
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 64
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up 64
Role of subcutaneous abdominal fat on cardiac function and proinflammatory cytokines in premenopausal obese women 63
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 63
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 63
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 63
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 63
Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes 62
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 62
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 61
Metformin: An old drug against old age and associated morbidities 60
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 56
Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review 55
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 54
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 51
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 51
Patients with adrenal insufficiency have cardiovascular features associated with hypovolemia 50
Cardiovascular Therapeutics at the Crossroads: Pharmacological, Genetic, and Digital Frontiers 47
Metformin Lactic Acidosis: should we still be afraid? 46
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 38
Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm 25
Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study 15
Impact of achieving glycated hemoglobin targets on cardiovascular events/mortality: Post-hoc analysis of the nephropathy in diabetes type 2 trial 13
Micro- and Nanoplastics as Disruptors of Digestive and Hepatopancreatic Homeostasis: Insights into the Plastic-Gut-Liver Axis 2
Totale 5.973
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.582
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 2 0 0 0 0 2 1 1 2 0 2
2022/202347 5 1 0 3 2 2 0 3 25 1 5 0
2023/202493 3 2 2 2 4 15 3 7 1 5 5 44
2024/2025862 130 48 95 11 139 13 22 49 88 23 107 137
2025/20264.883 157 396 816 329 961 887 412 137 212 371 167 38
2026/202751 51 0 0 0 0 0 0 0 0 0 0 0
Totale 5.973